Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1989-06-27
1992-01-14
Kepplinger, Esther L.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
530387, 424 858, 4351722, 435 7021, C12N 520, C12N 1502, C07K 1528, C12P 2108
Patent
active
050810324
ABSTRACT:
Anti-human pulmonary adenocarcinoma monoclonal antibody ALC-864 which belongs to the class IgG.sub.1, reacts with human pulmonary adenocarcinoma cells but not with normal human cells, recognizes proteins as antigens, and is useful for the identification of pulmonary adenocarcinoma selectively from among normal cells and for distinguishing this cancer from among other types of cancer.
REFERENCES:
Hellstrom et al., Cancer Res. 46:3917-23, 1986.
Mazauric et al., Cancer Res. 42:150, 1982.
Radosevich et al., Cancer Res. 45:5808, 1985.
Hanai et al., Cancer Res. 46:4438, 1986.
Kipps et al., pp. 108-1-108.9 in Weir et al. Eds., Handbook of Exptl. Immunol., vol. 1, Blackwell Sci. Publ., 1986.
Campbell, Monoclonal Antibody Technology, Elsevier Press, 1984, 265 pages.
Johnston et al., Cancer Res. 46:6462, 1986.
Shitara Kenya
Yoshida Hajime
Hutzell Paula
Kepplinger Esther L.
Kyowa Hakko Kogyo Co. Ltd.
LandOfFree
Anti-human pulmonary adenocarcinoma monoclonal antibody does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-human pulmonary adenocarcinoma monoclonal antibody, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-human pulmonary adenocarcinoma monoclonal antibody will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-540995